
Melly M
@mmaerklin
ID: 1444335873118638085
02-10-2021 16:18:36
53 Tweet
37 Followers
36 Following

After the AACR, the Translational Immunology is back in the US for #NK2022! After a beach day we showcase some of our latest research in tomorrow’s poster session. Check out posters #57 #69 #87 #90 #110 and get in touch!


What is the future of peptide-based #immunotherapy? Our member Juliane Walz gave interesting insights into #cancer immunotherapy as part of the newest episode of @MedTrib_medizin #podcast 🎙️ "O-Ton #Onkologie" Tune in: bit.ly/3bEajZh (only in 🇩🇪) #CancerResearch




On Wednesday we dressed up for our annual #whiteparty with Peptide-based Immunotherapy. What a night🥳



We are hiring! Interested in translational #research in cancer #immunotherapy? Explore the positions we have to offer and join the team! #job #Postdoc #Researcher #PhDStudent #labtechnician jobs.medizin.uni-tuebingen.de/Job/3285/Wisse… jobs.medizin.uni-tuebingen.de/Job/3288/Natur… jobs.medizin.uni-tuebingen.de/Job/3283/MTA--…

Melanie Märklin Melly M, Polina Kaidun, Sylwia Stefańczyk Sylwia A. Stefańczyk and Samuel Holzmayer went to #CICON2023 #Milan to present their work. I guess one has to conclude that today they are warming up for the meeting by sightseeing… Cancer Immunotherapy

Excited to be at #CICON23 in #Milan! 🇮🇹 Ready to dive into the world of #cancer #immunotherapy with experts from around the globe. Let’s explore groundbreaking advancements together! #CancerImmunotherapy #MilanConference Cancer Immunotherapy AACR Cancer Research Institute Translational Immunology 🌟🔬🤝


Congratulations to Christopher Hackenbruch for the „Rudolf Schindler“ abstract #award of the #DGVS presenting our FusionVAC22_01 #clinicaltrial for #FLHCC. Pleased to start at Translational Immunology with Michael Bitzer, supported by Faculty of Medicine Tuebingen Else Kröner-Fresenius-Stiftung / #ForTra Roche #Immunotherapy


Great day with my colleagues at #CICON23 Translational Immunology Sylwia A. Stefańczyk



Today at #CICON23 #Milan: Sylwia Stefańczyk Sylwia A. Stefańczyk presented her results on induction of NK cell reactivity against acute myeloid leukemia by FC-optimized B7-H3 antibodies. #AML #leukemia #Immunotherapy



Innovative treatment opportunity Translational Immunology Uniklinikum Tübingen for patients with biochemical recurrence of #prostate #cancer: the bispecific PSMAxCD3 #antibody CC-1. More information on the Phase I clinical trial at: medizin.uni-tuebingen.de/de/immuntherap…



